Objectives:

• Explain the role for immunotherapy in prostate cancer
• Interpret important differences between biochemically recurrent prostate cancer and metastatic castration resistant prostate cancer
• Interpret potential factors for failure of immune checkpoint inhibitors in prostate cancer
• Outline the potential role of cytokine-based immune strategies

Zoom:

Join from a PC, Mac, iPad, iPhone or Android device:

    Please click this URL to join. https://uwmadison.zoom.us/s/93162631923?pwd=a1lpZ2czVUllOWFMYXcxSWVzRjhkUT09

    Passcode: Grand

Or One tap mobile:  +13126266799,,93162631923# US (Chicago); +16469313860,,93162631923# US

Or join by phone: Dial(for higher quality, dial a number based on your current location): US: +1 312 626 6799  or +1 646 931 3860  or +1 929 205 6099  or +1 301 715 8592  or +1 305 224 1968  or +1 309 205 3325  or +1 346 248 7799  or +1 360 209 5623  or +1 386 347 5053  or +1 507 473 4847  or +1 564 217 2000  or +1 669 444 9171  or +1 669 900 6833  or +1 689 278 1000  or +1 719 359 4580  or +1 253 205 0468  or +1 253 215 8782

Webinar ID: 931 6263 1923;  International numbers available: https://uwmadison.zoom.us/u/atFRJJdfV

Or an H.323/SIP room system:

    H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East); Webinar ID: 931 6263 1923; Passcode: 868562

SIP: 93162631923@zoomcrc.com; Passcode: 868562